MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze HUM →
    • FindStock Picks / Stock Screener
    • Value · HUMIntrinsic Value Calculator
    • Invest · HUMInvestment Case
    • Hold · HUM5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
HUM stock logo

HUM

Humana Inc.

$389.91
9.91
 (2.61%)
Exchange:  NYSE
Market Cap:  46.829B
Shares Outstanding:  120.454M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – Healthcare PlansView industry performance
   
CEO:  James A. Rechtin
Full Time Employees:  67060
Address: 
Humana Building
Louisville
KY
40202
US
Website:  https://www.humana.com
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana’s reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Click to read more…

Revenue Segmentation

Revenue by type

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

HUM full analysis

20/11/2026

Welcome to MarketSnap. Humana is up about 66% over the past year — one of the best performers in healthcare — and it hit a 52-week high just last week. Then it fell roughly 15% in five days on a single proposed Medicare Advantage audit rule called CRUSH. The question that raises isn't really whether a 15% fall makes a beaten-up insurer cheap; it's whether the market is finally pricing a risk the rally had been ignoring. That's the whole…

Listen to full analysis (audio file)

Open in MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
HUHUM logoHUMHumana Inc.46.8B43.440.74.4%
CNCNC logoCNCCentene Corp.31.6B24.112.11.9%
CICI logoCICigna Corporation71.4B13.18.87.4%
MOMOH logoMOHMolina Healthcare, Inc.10.4B—37.72.1%
ELELV logoELVElevance Health Inc.85.2B18.313.57.5%
OSOSCR logoOSCROscar Health, Inc.6.4B11.210.532.5%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/11/06 — 3 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue106,440,000117,811,000129,664,000
Gross Profit18,046,00017,147,00018,852,000
EBITDA4,730,0003,255,0002,908,000
Operating Income3,320,0001,627,0001,453,000
Net Income2,489,0001,207,0001,188,000

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets47,065,00046,479,00048,909,000
Total Liabilities30,747,00030,034,00031,172,000
Total Stockholders Equity16,262,00016,375,00017,657,000
Total Debt11,656,00011,721,00012,369,000
Cash and Cash Equivalents4,694,0002,221,0004,200,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow3,981,0002,966,000921,000
Capital Expenditure-1,004,000-575,000-546,000
Free Cash Flow2,977,0002,391,000375,000
Net Income2,489,0001,214,0001,203,000
Net Change in Cash-367,000-2,473,0001,979,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)202,360,166.289Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)222,449,027.954Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)213,015,500Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)7,520,542.856Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)8,233,228.883Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)7,898,558.712Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)4,298,468.355Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)4,862,109.567Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)4,597,429.338Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)0Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)0Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)0Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)38.050Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)40.240Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)35.580Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)10Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)4Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
117.811B  ?P/S
 (TTM)
: 
0.35
?Net Income
 (TTM)
: 
1.207B  ?P/E
 (TTM)
: 
43.35
?Enterprise Value
 (TTM)
: 
59.615B  ?EV/FCF
 (TTM)
: 
79.81
?Dividend Yield
 (TTM)
: 
0.79%  ?Payout Ratio
 (TTM)
: 
34.46%
?ROE
 (TTM)
: 
6.71%  ?ROIC
 (TTM)
: 
4.39%
?Net Debt
 (TTM)
: 
10.039B  ?Debt/Equity
 (TTM)
: 
0.66
?P/B
 (TTM)
: 
2.87  ?Current Ratio
 (TTM)
: 
1.65

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
40.74Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

Strengths (preview)

  • Momentum and guidance revision: 3Q26 results exceeded initial guidance, prompting an upward revision of full-year 2026 adjusted EPS to at least $9.50 (from at least $9.00). The stock hit a 52-week high in mid-November 2026, with 1-year performance of +66.01% and 6-month performance of +22.36%, materially outperforming the industry (+28.82% 1Y).
  • Medicare Advantage margin trajectory: Management reports being on track to double individual MA pretax margin in 2026 (excluding the Stars headwind), with a stated target of 3%+ margin by 2028 and top-quartile Star ratings expected by 2029. Strong Medicare ratings were confirmed in the news flow, supporting membership retention and quality bonus potential.
  • Diversified revenue base and adjacent growth engines: FY2025 revenue of $129.7B comprises a $124.6B Insurance segment plus a $22.5B CenterWell segment, with ongoing expansion of CenterWell Primary Care and the Medicaid footprint. The newly announced oncology model aims to accelerate cancer treatment and reduce administrative friction within the value-based care strategy.

Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Research Access for the complete SWOT analysis.

Create a free account

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates HUM intrinsic value between $184.52 – $313.16 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate HUM Intrinsic Value

Common questions about HUM valuation

Is Humana Inc. (HUM) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Humana Inc. (HUM) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is HUM a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether HUM trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is HUM’s P/E ratio?

You can see HUM’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for HUM?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is HUM a good long-term investment?

Whether HUM fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Humana Inc.

  • Humana Inc. intrinsic value calculatorEstimate what the business is worth
  • Humana Inc. 5-year outlookWhat has to go right, and what could go wrong
HUM

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

2.61
MarketSnap

Trading Metrics:

Open: 393.95   Previous Close: 380
Day Low: 387.83   Day High: 401.98
Year Low: 163.11   Year High: 462.87
Price Avg 50: 409.98   Price Avg 200: 321.86
Volume: 2.103M   Average Volume: 1.424M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

Humana Is Up More Than 50% This Year, but $1,000 From Three Years Ago Is Still Worth Less Than $1,000
20-11-2026 15:51
Humana Is Up More Than 50% This Year, but $1,000 From Three Years Ago Is Still Worth Less Than $1,000
Humana: The Proposed CRUSH Rule Creates A Buying Opportunity
19-11-2026 16:14
Humana: The Proposed CRUSH Rule Creates A Buying Opportunity
Humana Inc. (HUM) Hit a 52 Week High, Can the Run Continue?
17-11-2026 10:16
Humana Inc. (HUM) Hit a 52 Week High, Can the Run Continue?
Humana Foundation Marks 45 Years With Nearly $14 Million in Grants to Expand Healthy Food Access and Help Seniors Feel More Connected
17-11-2026 10:00
Humana Foundation Marks 45 Years With Nearly $14 Million in Grants to Expand Healthy Food Access and Help Seniors Feel More Connected
Humana Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
16-11-2026 20:57
Humana Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
Humana Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
16-11-2026 17:02
Humana Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze HUM →
    • FindStock Picks / Stock Screener
    • Value · HUMIntrinsic Value Calculator
    • Invest · HUMInvestment Case
    • Hold · HUM5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.